Biopure Corporation
Based on the review, we recommend the Biopure Corporation to launch their animal blood substitute, Oxyglobin, immediately in the market, so that it open up a way in the animal market sector and the company can gain more revenue before they launch their next product, which is the human blood substitute, Hemopure.
Customers
Biopure Corporation produces blood substitute for both human and animal patients that are shelf-stable at room temperature. They are made from blood of cattle that had been purified and gone through the production process. The potential customers for Hemopure are coming from the hospitals that may range from patients with chronic anemia acute blood loss and patients who need RBC transfusions during surgeries such as heart bypass or organs transplant. Other potential customers of Hemopure may also be the trauma cases victims.
On the other hand, Oxyglobin are the blood substitutes created for animals. The potential customers for Oxyglobin are coming from the primary are and emergency veterinarian service provider. These customers who need the blood transfusion come from animals, which are suffering from acute blood loss. The high amount of blood transfusion is also needed during the canine surgeries, practice handling and canine trauma cases. In contrast to the human market, there are not much animals banks around and the main animal blood supply is from animals that were at the animal hospital.
Company
Biopure Corporation is company specialized in ultra purification of proteins for human and veterinary use. With its skills, Biopure created two types of blood substitutes, human and animal, and entered the market of blood substitute. Both Hemopure and Oxyglobin used the same equipment and went through ...